Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Cancer
|
July 27, 1999
A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques
B Dautzenberg, R Arriagada, A B Chammard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 1, 1992
Disappearance of the in situ component: a criterion predictive of metastasis in breast cancer after local relapse
B Chauvet, A Lemseffer, F Fetissoff, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 30, 1993
Place of Iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas
J J Mazeron, Y Belkacemi, J M Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2003
Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up
L Zelek, A Llombart-Cussac, P Terrier, et al.
Dermatology Research and Practice
|
June 14, 2012
Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases
O Hocar, A Le Cesne, S Berissi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Management of breast cancer in the elderly
L M Martin, C le Pechoux, E Calitchi, et al.
The British Journal of Radiology
|
April 16, 2015
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective
S Adebahr, S Collette, E Shash, et al.
Revue Des Maladies Respiratoires
|
February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]
J Tredaniel, F Mornex, I Barillot, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Critical factors for patient management
V Ninane, C Le Pechoux, W Curran, et al.
ESMO Open
|
March 7, 2022
Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials
E F Nassif, J-Y Blay, C Massard, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Cancer
|
July 27, 1999
A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques
B Dautzenberg, R Arriagada, A B Chammard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 1, 1992
Disappearance of the in situ component: a criterion predictive of metastasis in breast cancer after local relapse
B Chauvet, A Lemseffer, F Fetissoff, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 30, 1993
Place of Iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas
J J Mazeron, Y Belkacemi, J M Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2003
Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up
L Zelek, A Llombart-Cussac, P Terrier, et al.
Dermatology Research and Practice
|
June 14, 2012
Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases
O Hocar, A Le Cesne, S Berissi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Management of breast cancer in the elderly
L M Martin, C le Pechoux, E Calitchi, et al.
The British Journal of Radiology
|
April 16, 2015
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective
S Adebahr, S Collette, E Shash, et al.
Revue Des Maladies Respiratoires
|
February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]
J Tredaniel, F Mornex, I Barillot, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Critical factors for patient management
V Ninane, C Le Pechoux, W Curran, et al.
ESMO Open
|
March 7, 2022
Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials
E F Nassif, J-Y Blay, C Massard, et al.
Page
of 3